Tempest Therapeutics, Inc. (TPST)
USD 0.7
(-11.57%)
USD 0.7
(-11.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.35 Million | -31.07 Million | -25.95 Million | -19.01 Million | -41.22 Million | -23.64 Million |
| Net Income | -29.49 Million | -35.7 Million | -28.3 Million | -19.2 Million | -44.56 Million | -27.19 Million |
| Depreciation & Amortization | 381 Thousand | 638 Thousand | 374 Thousand | 339 Thousand | 1.05 Million | 32 Thousand |
| Deferred income taxes | -3.57 Million | - | - | - | -2.57 Million | - |
| Stock-based compensation | 2.54 Million | 1.56 Million | 1.1 Million | 453 Thousand | 310 Thousand | 1.42 Million |
| Change in working capital | -2.67 Million | 868 Thousand | -613 Thousand | -1.07 Million | -2.05 Million | 1.03 Million |
| Other non-cash items | 5.45 Million | 1.57 Million | 1.47 Million | 470 Thousand | 6.92 Million | 2.22 Million |
| Investing Cash Flow | -170 Thousand | -562 Thousand | -97 Thousand | -6000.00 | 3.98 Million | 1.12 Million |
| Investments in PPE | -170 Thousand | -562 Thousand | -135 Thousand | -50 Thousand | -397 Thousand | -36 Thousand |
| Acquisitions | - | - | - | - | - | -1.33 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 4.38 Million | 2.49 Million |
| Other Investing Activities | - | - | 38 Thousand | 44 Thousand | - | 476 Thousand |
| Financing Cash Flow | 35.6 Million | 11.4 Million | 59.06 Million | 34.59 Million | 26.94 Million | 78.55 Million |
| Debt repayment | - | -4.73 Million | -14.9 Million | -37 Thousand | -202 Thousand | -6.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 35.6 Million | 8.86 Million | 33.42 Million | 34.59 Million | 27.14 Million | 38.75 Million |
| Other Financing Activities | 35.6 Thousand | 7.28 Million | 40.54 Million | 34.59 Million | 23 Million | 33.31 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -263 Thousand | 1000.00 | -209 Thousand | -574 Thousand | -469 Thousand | 320 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.41 Million | 867 Thousand | -404 Thousand | -497 Thousand | -1.58 Million | 716 Thousand |
| Cash at beginning of period | 31.23 Million | 51.82 Million | 18.82 Million | 3.24 Million | 73.33 Million | 17.62 Million |
| Cash at end of period | 39.23 Million | 31.59 Million | 51.82 Million | 18.82 Million | 63.51 Million | 73.33 Million |
| Capital Expenditure | -170 Thousand | -562 Thousand | -135 Thousand | -50 Thousand | -397 Thousand | -36 Thousand |
| Effect of forex changes on cash | -793 Thousand | - | - | 221 Thousand | 33 Thousand | 118 Thousand |
| Net cash flow / Change in cash | 8 Million | -20.23 Million | 33 Million | 15.57 Million | -9.81 Million | 55.7 Million |
| Free Cash Flow | -27.52 Million | -31.63 Million | -26.09 Million | -19.06 Million | -41.61 Million | -23.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.57 Million | -7.9 Million | -7.48 Million | -29.49 Million | -6.78 Million | -7.58 Million |
| Depreciation & Amortization | 155 Thousand | 88 Thousand | 85 Thousand | 381 Thousand | 88 Thousand | 83 Thousand |
| Deferred income taxes | - | - | -1.55 Million | -3.57 Million | - | - |
| Stock-based compensation | 1.32 Million | 1.31 Million | 1.09 Million | 2.54 Million | 563 Thousand | 440 Thousand |
| Change in working capital | 2.17 Million | -1.17 Million | -343 Thousand | -2.67 Million | -820 Thousand | 209 Thousand |
| Other non-cash items | 1.73 Million | 1.77 Million | 2.03 Million | 5.45 Million | 468 Thousand | 457 Thousand |
| Investing Cash Flow | -249 Thousand | -168 Thousand | -7000.00 | -170 Thousand | - | -117 Thousand |
| Investments in PPE | -249 Thousand | -168 Thousand | -7000.00 | -170 Thousand | - | -117 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.55 Million | 450 Thousand | 34.34 Million | 35.6 Million | 21 Thousand | 1.18 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.55 Million | 450 Thousand | 34.34 Million | 35.6 Million | 21 Thousand | 1.18 Million |
| Other Financing Activities | 4.55 Million | 197 Thousand | 34.34 Thousand | 35.6 Thousand | 21.00 | 1188.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 306 Thousand | 206 Thousand | -291 Thousand | -263 Thousand | 268 Thousand | -252 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.86 Million | -1.38 Million | -52 Thousand | -2.41 Million | -1.08 Million | 461 Thousand |
| Cash at beginning of period | 32.32 Million | 39.23 Million | 11.11 Million | 31.23 Million | 17.97 Million | 23.29 Million |
| Cash at end of period | 31.12 Million | 32.32 Million | 39.23 Million | 39.23 Million | 11.5 Million | 17.97 Million |
| Capital Expenditure | -249 Thousand | -168 Thousand | -7000.00 | -170 Thousand | - | -117 Thousand |
| Effect of forex changes on cash | - | - | -55 Thousand | -793 Thousand | - | - |
| Net cash flow / Change in cash | -1.2 Million | -6.9 Million | 28.11 Million | 8 Million | -6.46 Million | -5.32 Million |
| Free Cash Flow | -5.75 Million | -7.35 Million | -6.18 Million | -27.52 Million | -6.48 Million | -6.5 Million |
8957
ISUR
600572
301007
ITCFY
III